The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat ...

Novartis used one of its priority review vouchers (PRV) to speed the September approval of Kisqali in early breast cancer, ...

The FDA expanded approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease. The decision will free up access to the medication for tens of ...

On September 3, OBX-115, a novel TIL therapy, was granted FDA regenerative medicine advanced therapy (RMAT) designation in ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no longer in shortage after nearly two years. Pharmacies that sold ...

Can men get breast cancer? The simple answer is yes. Although breast cancer is rare in men, here three signs you need to know ...

Liquidia Technologies (LQDA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

October marks Breast Cancer Awareness Month, an annual worldwide campaign to promote regular screening and early detection of breast cancer. According to the National Breast Cancer Foundation, one in ...

Major U.S. stock indices ended in the green on Oct. 8, buoyed by strong earnings reports from a handful of tech stocks. Comparatively steadier U.S. treasury yields also boosted investors’ optimism, ...

A head-to-head study has revealed that CSL and Arcturus Therapeutic’s self-amplifying mRNA vaccine can maintain a stronger immune response than a conventional mRNA vaccine for up to one year and at a ...

FN Media Group News Commentary - Breast cancer is an illness in which the breast cells get uncontrollably large. The type of breast cancer depends on which cells in the breast become cancerous. Cancer ...

It doesn’t have to be all gloom and doom. Here are six ways to beat the side effects of breast cancer treatments.